270 related articles for article (PubMed ID: 32355785)
1.
Wu G; Zhao Z; Yan Y; Zhou Y; Wei J; Chen X; Lin W; Ou C; Li J; Wang X; Xiong K; Zhou J; Xu Z
Ann Transl Med; 2020 Mar; 8(6):341. PubMed ID: 32355785
[TBL] [Abstract][Full Text] [Related]
2. Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.
Çeliktas M; Tanaka I; Tripathi SC; Fahrmann JF; Aguilar-Bonavides C; Villalobos P; Delgado O; Dhillon D; Dennison JB; Ostrin EJ; Wang H; Behrens C; Do KA; Gazdar AF; Hanash SM; Taguchi A
J Natl Cancer Inst; 2017 Mar; 109(3):1-9. PubMed ID: 28376202
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of CPS1 in glioblastoma multiforme.
Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z
Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588
[TBL] [Abstract][Full Text] [Related]
4. CFHR1 is a potentially downregulated gene in lung adenocarcinoma.
Wu G; Yan Y; Wang X; Ren X; Chen X; Zeng S; Wei J; Qian L; Yang X; Ou C; Lin W; Gong Z; Zhou J; Xu Z
Mol Med Rep; 2019 Oct; 20(4):3642-3648. PubMed ID: 31485643
[TBL] [Abstract][Full Text] [Related]
5. Roles of highly expressed PAICS in lung adenocarcinoma.
Zhou S; Yan Y; Chen X; Wang X; Zeng S; Qian L; Wei J; Yang X; Zhou Y; Gong Z; Xu Z
Gene; 2019 Apr; 692():1-8. PubMed ID: 30641222
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
7. A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma.
Wang X; Xu Z; Chen X; Ren X; Wei J; Zhou S; Yang X; Zeng S; Qian L; Wu G; Gong Z; Yan Y
PeerJ; 2019; 7():e7125. PubMed ID: 31245181
[TBL] [Abstract][Full Text] [Related]
8. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
Zhang QH; Dai XH; Dai ZM; Cai YN
Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of dipeptidyl peptidase‑like 6 as a potential prognostic biomarker for lung adenocarcinoma.
Munkhjargal B; Kondo K; Soejima S; Tegshee B; Takai C; Kawakita N; Toba H; Takizawa H
Oncol Lett; 2023 May; 25(5):206. PubMed ID: 37123021
[TBL] [Abstract][Full Text] [Related]
10. A five-m6A regulatory gene signature is a prognostic biomarker in lung adenocarcinoma patients.
Wu X; Sheng H; Wang L; Xia P; Wang Y; Yu L; Lv W; Hu J
Aging (Albany NY); 2021 Mar; 13(7):10034-10057. PubMed ID: 33795529
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of decreased GRK6 expression in lung adenocarcinoma.
Yao S; Zhong L; Liu J; Feng J; Bian T; Zhang Q; Chen J; Lv X; Chen J; Liu Y
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2541-2549. PubMed ID: 27601164
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a Carbamoyl Phosphate Synthetase 1-Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis.
Wu T; Luo G; Lian Q; Sui C; Tang J; Zhu Y; Zheng B; Li Z; Zhang Y; Zhang Y; Bao J; Hu J; Shen S; Yang Z; Wu J; Wang K; Zhao Y; Yang S; Wang S; Qiu X; Wang W; Wu X; Wang H; Gu J; Chen L
Hepatology; 2021 Dec; 74(6):3249-3268. PubMed ID: 34343359
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of KCNJ4 correlates with cancer progression and unfavorable prognosis in lung adenocarcinoma.
Wu XY; Yu XY
J Biochem Mol Toxicol; 2019 Apr; 33(4):e22270. PubMed ID: 30512237
[TBL] [Abstract][Full Text] [Related]
14. miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2.
Wang H; Kanmangne D; Li R; Qian Z; Xia X; Wang X; Wang T
Oncol Rep; 2020 Feb; 43(2):646-654. PubMed ID: 31894275
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling of CPS1 in Correa's cascade and its association with gastric cancer prognosis.
Fang X; Wu X; Xiang E; Luo F; Li Q; Ma Q; Yuan F; Chen P
Oncol Lett; 2021 Jun; 21(6):441. PubMed ID: 33868479
[TBL] [Abstract][Full Text] [Related]
16. Identifying
Liu XT; Liu TT; Wu MY; Chen QX; Zhuang JX; Wang Q
Genet Test Mol Biomarkers; 2021 Jan; 25(1):68-78. PubMed ID: 33470885
[No Abstract] [Full Text] [Related]
17. Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods.
Sun R; Ma C; Wang W; Yang S
PeerJ; 2020; 8():e8420. PubMed ID: 32095325
[TBL] [Abstract][Full Text] [Related]
18. Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma.
Ma SL; Li AJ; Hu ZY; Shang FS; Wu MC
Mol Med Rep; 2015 Dec; 12(6):7915-26. PubMed ID: 26499888
[TBL] [Abstract][Full Text] [Related]
19. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma.
Chen S; Lu Z; Chen X; Wu X; Tu H; Yu L; Xiao Z
Oncol Lett; 2020 Nov; 20(5):147. PubMed ID: 32934715
[TBL] [Abstract][Full Text] [Related]
20. Function of low ADARB1 expression in lung adenocarcinoma.
Wang X; Xu Z; Ren X; Chen X; Wei J; Lin W; Li Z; Ou C; Gong Z; Yan Y
PLoS One; 2019; 14(9):e0222298. PubMed ID: 31491024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
